Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients
Open Access
- 20 July 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 21 (11) , 1383-1394
Abstract
Noninvasive serum fibrosis biomarkers predict clinical outcomes in pretransplant patients with chronic liver disease. We investigated the role of serum fibrosis biomarkers and of changes in biomarkers in predicting death and graft loss after liver transplantation (LT). We included 547 patients who underwent LT between 1991 and 2012 and who met the following criteria: patient and graft survival > 12 months; serum fibrosis biomarkers aspartate aminotransferase–to‐platelet ratio index (APRI), fibrosis score 4 (FIB‐4), and nonalcoholic fatty liver disease (NAFLD) fibrosis score available at 1 year after LT; and a minimum follow‐up of 1 year. Delta of fibrosis biomarkers was defined as (end of follow‐up score – baseline score)/follow‐up duration. Baseline and delta fibrosis biomarkers were associated with death: APRI > 1.5 (adjusted hazard ratio [aHR], 2.2; 95% confidence interval [CI], 1.4‐3.3; P < 0.001) and delta APRI > 0.5 (aHR, 5.3; 95% CI, 3.4‐8.2; P < 0.001); FIB‐4 > 3.3 (aHR, 1.9; 95% CI, 1.3‐2.8; P = 0.002) and delta FIB‐4 > 1.4 (aHR, 2.4; 95% CI, 1.4‐4.1; P = 0.001); and NAFLD fibrosis score > 0.7 (aHR, 1.9; 95% CI, 1.3‐2.9; P = 0.002) and delta NAFLD fibrosis score (aHR, 3.7; 95% CI, 2.6‐5.4; P < 0.001). Baseline and delta fibrosis biomarkers were associated also with graft loss. In conclusion, serum fibrosis biomarkers 1 year after LT and changes in serum fibrosis biomarkers predict death and graft loss in LT recipients. They may help in risk stratification of LT recipients and identify patients requiring closer monitoring. Liver Transpl 21:1383‐1394, 2015. © 2015 AASLD.Keywords
This publication has 36 references indexed in Scilit:
- Ultrasound-Based Transient Elastography for the Detection of Hepatic Fibrosis in Patients With Recurrent Hepatitis C Virus After Liver Transplantation: A Systematic Review and Meta-AnalysisLiver Transplantation, 2012
- Transient elastography identifies liver recipients with nonviral graft disease after transplantation: A guide for liver biopsyLiver Transplantation, 2012
- Chances and limitations of non‐invasive tests in the assessment of liver fibrosis in liver transplant patientsClinical Transplantation, 2009
- Liver biopsy†Hepatology, 2009
- Exceeding the limits of liver histology markersJournal of Hepatology, 2009
- FIB-4Hepatology, 2007
- The NAFLD fibrosis scoreHepatology, 2007
- Sampling Variability of Liver Fibrosis in Chronic Hepatitis CHepatology, 2003
- Sampling variability of liver fibrosis in chronic hepatitis CHepatology, 2003
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis CHepatology, 2003